The role of the innate immune system in the development and treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Most patients present with advanced or metastatic HCC at diagnosis and face a dismal prognosis. Tyrosine kinases are the gold standard treatment for this disease but yield limited survival benefits. Immune checkpoint inhibitors...
| 出版年: | Hepatic Oncology |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Taylor & Francis
2020-03-01
|
| 主題: | |
| オンライン･アクセス: | https://www.futuremedicine.com/doi/10.2217/hep-2019-0007 |